Hydrogen Therapy Shows Promise for Organ Transplant Complications

Scientists found that hydrogen gas might help protect organs after transplants by reducing damage and swelling, which could make transplants work better and last longer in patients who receive them.

Animal studies show hydrogen gas may reduce transplant-related complications by decreasing oxidative stress and inflammatory responses in both the transplanted organ and the body's systemic circulation.

This review examined whether hydrogen gas might help prevent complications after organ transplants, specifically graft-versus-host disease (a condition where transplanted cells attack the recipient's body) and ischemia-reperfusion injury (damage that occurs when blood flow is restored to a transplanted organ). The authors found that in animal studies, hydrogen gas—either inhaled or dissolved in salt water—reduced harmful inflammation and oxidative stress (cellular damage from unstable molecules) in transplanted organs and throughout the body, potentially improving transplant outcomes.

While these findings are promising, they come entirely from animal research—no human clinical trials of hydrogen for transplant complications have been completed yet. Anyone involved in organ transplantation should discuss any experimental therapies with their transplant team rather than pursuing hydrogen water independently, as the clinical relevance and safety in humans remain unknown.

Post-transplant complications such as graft-versus-host disease and graft ischemia-reperfusion injury are crucial challenges in transplantation. Hydrogen can act as a potential antioxidant, playing a preventive role against post-transplant complications in animal models of multiple organ…

Read the full abstract on PubMed